HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lars Bo Andersen Selected Research
Lars Bo Andersen Research Topics
Disease
13
Insulin Resistance
02/2019 - 07/2006
5
Obesity
01/2022 - 09/2004
5
Overweight
11/2019 - 05/2010
4
Neoplasms (Cancer)
01/2020 - 11/2013
4
Cardiovascular Diseases (Cardiovascular Disease)
07/2019 - 06/2005
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2014 - 06/2008
2
Birth Weight (Birth Weights)
10/2020 - 01/2011
2
Athletic Injuries (Sports Injuries)
12/2018 - 06/2014
2
Weight Gain
01/2017 - 01/2012
2
Inflammation (Inflammations)
12/2015 - 05/2010
1
Bone Resorption
01/2022
1
Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2017
1
Cumulative Trauma Disorders (Repetitive Strain Injury)
06/2014
1
Wounds and Injuries (Trauma)
04/2014
1
Hip Osteoarthritis (Coxarthrosis)
02/2014
1
Type 2 Diabetes Mellitus (MODY)
12/2009
1
Genetic Predisposition to Disease (Genetic Predisposition)
12/2009
1
Breast Neoplasms (Breast Cancer)
06/2008
1
Hypertension (High Blood Pressure)
09/2004
Drug/Important Bio-Agent (IBA)
8
Triglycerides (Triacylglycerol)
IBA
10/2020 - 07/2006
8
HDL Cholesterol
IBA
10/2020 - 07/2006
7
Insulin (Novolin)
FDA Link
01/2017 - 06/2005
4
Lipids
IBA
07/2019 - 06/2005
4
Cholesterol
IBA
10/2018 - 09/2004
4
Glucose (Dextrose)
FDA Link
Generic
01/2015 - 06/2005
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 05/2010
2
Interleukin-6 (Interleukin 6)
IBA
01/2012 - 04/2010
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
01/2022
1
Procollagen Type I
IBA
01/2022
1
Osteocalcin
IBA
01/2022
1
Collagen
IBA
01/2022
1
LDL Cholesterol
IBA
10/2020
1
Nerve Growth Factors (Neurotrophins)
IBA
11/2019
1
oxidized low density lipoprotein
IBA
09/2018
1
Endocannabinoids
IBA
01/2017
1
Proteins (Proteins, Gene)
FDA Link
12/2015
1
HDL Lipoproteins
IBA
10/2014
1
A-factor (Streptomyces)
IBA
04/2014
1
Adiponectin
IBA
05/2010
1
Dietary Proteins
IBA
05/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2010
1
C-Reactive Protein
IBA
04/2010
1
Dietary Fats (Dietary Fat)
IBA
01/2009
1
N-(4-ethoxybenzylidene)-4-butylaniline
IBA
06/2008
1
ORALIT (ORS)
IBA
09/2004
Therapy/Procedure
2
Therapeutics
01/2020 - 11/2013
2
Aftercare (After-Treatment)
01/2020 - 01/2017
2
Drug Therapy (Chemotherapy)
09/2019 - 01/2017
2
Resistance Training
12/2018 - 06/2014
1
Withholding Treatment
01/2017
1
Hip Replacement Arthroplasty (Total Hip Replacement)
02/2014